Skip to main content
. 2008 Mar;29(3):608–612. doi: 10.3174/ajnr.A0871

Table 3:

Periprocedural complications within 30 days after CAS according to age or presenting event and treatment

Variable Unprotected CAS Protected CAS P*
Age ≤75 y
    No. 52 138
    Minor stroke, n/N (%) 4/52 (7.7) 5/138 (3.6) .3
    Major stroke, n/N (%) 0/52 (0) 0/138 (0) NA
    Death, n/N (%) 0/52 (0) 0/138 (0) NA
    Any stroke or death, n/N (%) 4/52 (7.7) 5/138 (3.6) .3
Age >75 y
    No. 16 37
    Minor stroke, n/N (%) 2/16 (12.5) 2/37 (5.4) .6
    Major stroke, n/N (%) 0/16 (0) 1/37 (2.7) 1.0
    Death, n/N (%) 0/16 (0) 1/37 (2.7) 1.0
    Any stroke or death, n/N (%) 2/16 (12.5) 4/37 (10.8) 1.0
Symptomatic patients
    No. 47 87
    Minor stroke, n/N (%) 5/47 (10.6) 5/87 (5.7) .3
    Major stroke, n/N (%) 0/47 (0) 0/87 (0) NA
    Death, n/N (%) 0/47 (0) 1/87 (1.1) 1.0
    Any stroke or death, n/N (%) 5/47 (10.6) 6/87 (6.9) 0.5
Asymptomatic patients
    No. 21 88
    Minor stroke, n/N (%) 1/21 (4.8) 2/88 (2.2) .5
    Major stroke, n/N (%) 0/21 (0) 1/88 (1.1) 1.0
    Death, n/N (%) 0/21 (0) 0/88 (0) NA
    Any stroke or death, n/N (%) 1/21 (4.8) 3/88 (3.4) .6

Note:—CAS indicates carotid angioplasty and stent placement; NA, not applicable.

*

P values are from χ2 analysis.

In the group of patients treated with cerebral protection devices, there was 1 nonstroke-related death secondary to pneumonia 3 weeks after the procedure.